Multiple Myeloma Stage III
2 clinical trials · Condition
◉ Watch Multiple Myeloma Stage III
| Record | Firm | Date |
|---|---|---|
| Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma (NCT03428373) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-01-17 |
Track Multiple Myeloma Stage III automatically
Every clearance here is in the API, with alerts when new ones post.